Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regen BioPharma (RGBPP) Return on Sales (2016 - 2025)

Historic Return on Sales for Regen BioPharma (RGBPP) over the last 11 years, with Q4 2025 value amounting to 4.28%.

  • Regen BioPharma's Return on Sales rose 44500.0% to 4.28% in Q4 2025 from the same period last year, while for Dec 2025 it was 4.28%, marking a year-over-year increase of 1100.0%. This contributed to the annual value of 5.39% for FY2025, which is 25600.0% down from last year.
  • As of Q4 2025, Regen BioPharma's Return on Sales stood at 4.28%, which was up 44500.0% from 9.64% recorded in Q3 2025.
  • Regen BioPharma's 5-year Return on Sales high stood at 0.33% for Q1 2025, and its period low was 9.64% during Q3 2025.
  • For the 5-year period, Regen BioPharma's Return on Sales averaged around 3.16%, with its median value being 2.18% (2022).
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 56900bps in 2023, then crashed by -62700bps in 2024.
  • Quarter analysis of 5 years shows Regen BioPharma's Return on Sales stood at 2.39% in 2021, then tumbled by -240bps to 8.15% in 2022, then skyrocketed by 70bps to 2.45% in 2023, then tumbled by -256bps to 8.73% in 2024, then surged by 51bps to 4.28% in 2025.
  • Its last three reported values are 4.28% in Q4 2025, 9.64% for Q3 2025, and 2.83% during Q2 2025.